282 related articles for article (PubMed ID: 4144595)
1. Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.
Gleichmann E; Gleichmann H
Klin Wochenschr; 1973 Mar; 51(6):260-5 concl. PubMed ID: 4144595
[No Abstract] [Full Text] [Related]
2. Immunosuppression and neoplasia. I. A critical review of experimental carcinogenesis and the immunesurveillance theory.
Gleichmann H; Gleichmann E
Klin Wochenschr; 1973 Mar; 51(6):255-9 contd. PubMed ID: 4147391
[No Abstract] [Full Text] [Related]
3. [Immunological supervision and carcinogenesis].
Gorelik LS
Usp Sovrem Biol; 1975; 80(2):270-86. PubMed ID: 55009
[No Abstract] [Full Text] [Related]
4. Development of tumors as a result of graft-versus-host reaction.
Cornelius EA
Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
[No Abstract] [Full Text] [Related]
5. The role of immunosuppression in the genesis and growth of malignant tumours.
Reis HE
Ger Med Mon; 1971; 1(1):16-21. PubMed ID: 4931500
[No Abstract] [Full Text] [Related]
6. Immunology in neoplasia relating to diagnosis, therapy and transplantation. Immunosuppression and oncogenesis.
Cerilli J; Hattan D
Am J Clin Pathol; 1974 Aug; 62(2):218-23. PubMed ID: 4602088
[No Abstract] [Full Text] [Related]
7. Immunosurveillance, regeneration and oncogenesis.
Prehn RT
Prog Exp Tumor Res; 1971; 14():1-24. PubMed ID: 4944395
[No Abstract] [Full Text] [Related]
8. Immunosuppression, virus and oncogenesis in mice.
Nehlsen SL
Transplant Proc; 1971 Mar; 3(1):811-3. PubMed ID: 4106340
[No Abstract] [Full Text] [Related]
9. Immunodepression and malignancy.
Stutman O
Adv Cancer Res; 1975; 22():261-422. PubMed ID: 766581
[No Abstract] [Full Text] [Related]
10. [Immunosuppression in cancer--depression of immunological function in the host from initiation to neoplasm-bearing state].
Kitagawa M
Nihon Rinsho; 1970 Jul; 28(7):1863-8. PubMed ID: 4918413
[No Abstract] [Full Text] [Related]
11. Role of immunologic disturbance in human oncogenesis: some facts and fancies.
Kaplan HS
Br J Cancer; 1971 Dec; 25(4):620-34. PubMed ID: 4401360
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression and oncogenic virus infections.
Hirsch MS; Black PH; Proffitt MR
Fed Proc; 1971; 30(6):1852-7. PubMed ID: 4330993
[No Abstract] [Full Text] [Related]
13. Immunosuppression and neoplasia.
Balner H
Rev Eur Etud Clin Biol; 1970; 15(6):599-604. PubMed ID: 4919177
[No Abstract] [Full Text] [Related]
14. Immunosuppression and cancer.
Vandeputte M
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):677-83. PubMed ID: 4340542
[No Abstract] [Full Text] [Related]
15. Immunologic activation of oncogenic viruses.
Phillips SM
Prog Exp Tumor Res; 1974; 19():37-44. PubMed ID: 4155103
[No Abstract] [Full Text] [Related]
16. Immunosuppressive chemotherapy and malignancy.
Schwartz RS
Transplant Proc; 1974 Dec; 6(4 Suppl 1):45-8. PubMed ID: 4612903
[No Abstract] [Full Text] [Related]
17. Letter: Lymphoid malignancy.
Russell AS; Percy J
Lancet; 1974 May; 1(7863):927. PubMed ID: 4133442
[No Abstract] [Full Text] [Related]
18. Effect of immunosuppression and cellular antigen on xenograft survival.
Cerilli J; Gideon L; Hattan D
Transplant Proc; 1970 Dec; 2(4):516-21. PubMed ID: 4939699
[No Abstract] [Full Text] [Related]
19. Malignancy as a complication of immunosuppressive therapy.
Leibowitz S; Schwartz RS
Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004
[No Abstract] [Full Text] [Related]
20. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression.
Hirsch MS
Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
